β Scribed by Metin Isik; Mehmet M. Seker; Hatice Odabas; Fahriye T. Kos; Dogan Uncu; Nurullah Zengin
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. The purposes of this study were to evaluate efficacy and toxicity of the combination of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site (CUP). ## METHODS. Patients with CUP received carboplatin AUC 5 mg/mL a minute intraven
## Abstract ## BACKGROUND The current study was performed to evaluate the efficacy and toxicity of a noncisplatinβbased chemotherapy regimen combining gemcitabine and docetaxel as frontβline chemotherapy for patients with carcinoma of an unknown primary site. ## METHODS Patients were to receive
tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.